LNAI
Lunai Bioworks Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.47
−30.63%Margins
Gross margin
-79.9%
EBITDA margin
-6097.9%
EBIT margin
—
Net margin
-6852.0%
FCF margin
—
0.0%
Return on equity
-0.0%
Return on assets
0.1%
Return on invested capital
0.00x
Asset turnover
-$5.3M
Cash from operations
$340
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026